Endowment / Foundation

Updated:

Children's Hospital of Philadelphia Foundation

The Children's Hospital of Philadelphia Foundation was established in 1983 to convert charitable giving into a durable funding engine for the hospital's...

Children's Hospital of Philadelphia Foundation logo

Children's Hospital of Philadelphia Foundation

The Children's Hospital of Philadelphia Foundation was established in 1983 to convert charitable giving into a durable funding engine for the hospital's clinical care, research, and community health programs. President and CEO Madeline Bell leads the effort, and the board draws operating expertise from corporate Philadelphia: Vice Chair Christopher Gheysens runs Wawa, Treasurer Seth Lehr is a partner at LLR Partners, and Secretary Brian M. McNeill co-founded Littlejohn & Co. Beyond traditional grantmaking, the foundation deploys capital directly into venture investments focused on pediatric medicine, digital health, and life sciences. The fund targets early-stage companies where innovation can improve outcomes for children — a mandate that spans therapeutics, medical devices, and health IT. The foundation's relationship with the hospital's research enterprise gives it a proprietary view into clinical needs and translational science; it can fund spinouts from CHOP's own labs or co-invest alongside venture firms that bring deal flow through board relationships. Corporate partners — including Wawa, through its own foundation, and NRG Energy via its 'Choose to Give' program — add a recurring capital base that supplements individual donations. The foundation operates from the CHOP campus in Philadelphia's University City district, adjacent to the Roberts Center for Pediatric Research and the Morgan Center for Research and Innovation. The physical proximity to CHOP's clinical and research operations is a sourcing advantage: the foundation can evaluate technologies emerging from the hospital's own physicians and scientists. The board includes executives with deep operating and investing experience — a governance structure that supports direct venture decisions alongside the professional investment team. In April 2025, Madeline Bell joined the board of Comcast, extending the foundation's network deeper into Philadelphia's corporate and technology ecosystem. What separates CHOP Foundation from most hospital-affiliated endowments is its direct venture posture. Where peer institutions typically invest through fund-of-funds or external managers, CHOP's foundation acts as a principal, funding companies whose products often become clinical tools inside the hospital itself. That feedback loop — from bedside need to venture investment to clinical deployment — makes the foundation a strategic investor rather than a passive allocator.

General information

Firm type

Endowment / Foundation

Year founded

1983

Location

Region

North America

Country

United States

City

Philadelphia

Corporate office

3401 Civic Center Blvd, Philadelphia, PA 19104, United States

Principals

Madeline Bell

President and CEO

Christopher Gheysens

Vice Chair of the Board of Trustees

Seth Lehr

Treasurer of the Board of Trustees

Brian M. McNeill

Secretary of the Board of Trustees

Sector focus

Digital HealthEnterprise SoftwareAI/MLHealthcare Services

Frequently asked questions

How does the Children's Hospital of Philadelphia Foundation source its venture deals?

The foundation sources deals through the clinical and research network of the hospital, including technologies spun out of CHOP's own labs. Board connections — particularly through Treasurer Seth Lehr at LLR Partners — provide additional venture deal flow, and the foundation's Philadelphia location gives it proximity to East Coast life-sciences clusters.

Is the foundation's venture activity structured as a separate fund or managed internally?

The foundation manages its venture investments internally, rather than through an external fund-of-funds structure. This direct-investment approach allows it to align capital deployment closely with the hospital's clinical priorities, and board members with private-equity and corporate-operating backgrounds participate in governance and investment oversight.

What investment stages does the CHOP Foundation target?

The foundation focuses on early-stage venture investments, typically backing companies at the seed through Series B stages. Its mandate favors technologies with a clear path to clinical application in pediatrics, where the hospital's research infrastructure can support validation and adoption.

Who makes investment decisions at the Children's Hospital of Philadelphia Foundation?

Decisions are overseen by President and CEO Madeline Bell and the Board of Trustees, which includes experienced investors and corporate executives. The board's composition — with members like LLR Partners partner Seth Lehr and Littlejohn & Co. co-founder Brian McNeill — embeds institutional investment judgment into the foundation's venture committee.

How does the foundation balance philanthropic mission with venture returns?

The foundation targets investments where commercial success directly advances child health: a profitable exit on a pediatric medical device or digital-therapeutic startup generates both a financial return for the endowment and a clinical tool the hospital can adopt. This dual-mandate approach treats venture returns as a sustainability mechanism for the foundation's charitable activities.

What is the relationship between the CHOP Foundation, Wawa, and NRG Energy?

Wawa and NRG Energy are significant corporate partners that provide recurring philanthropic capital to the foundation. Wawa's contributions flow through the Wawa Foundation, while NRG supports the foundation through its 'Choose to Give' employee-giving program. Both relationships diversify the foundation's funding base beyond individual donors.

Does the foundation invest in funds or only direct deals?

The foundation's known activity centers on direct venture investments. While some endowments blend direct deals with fund commitments, available information emphasizes the foundation's direct-investment posture — a choice that grants closer alignment with the hospital's clinical strategy and board expertise.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on endowments & foundations?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Philadelphia Endowment / Foundation profiles